JUNB and pancreatic neoplasm: Our results provide the first evidence that in concert with ERK activation, MUC1 modified the formation of AP-1 dimers to preferentially favor c-Jun:FRA-1, which in turn enhanced the migration and invasive potential of pancreatic cancer cells in vitro.